We have successfully completed the first stage: a feasibility study. Supported by government funding, we confirmed that our technology works and explored how it can be integrated into existing healthcare systems. Because medical innovation only makes a real impact when it fits within current care structures. We are receiving overwhelmingly enthusiastic support from both patients and gynecologists, recognizing the need for intervention solutions in HPV infections.
Now, we are looking for investors who want to join this meaningful mission to improve women’s health worldwide. The market potential is huge, and together we can make a real impact. Interested or looking for more information? Contact Remi Veenman
Spark’s director Medical Remi: “We believe in better healthcare. And right now, women’s health is lagging behind. By working closely with doctors and patient associations, we can create a product that saves women’s lives around the world.”